These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6709659)

  • 21. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens.
    Butler WB; Kelsey WH; Goran N
    Cancer Res; 1981 Jan; 41(1):82-8. PubMed ID: 7004631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A possible regulatory role of 17beta-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells.
    Rulli A; Antognelli C; Prezzi E; Baldracchini F; Piva F; Giovannini E; Talesa V
    Breast Cancer Res Treat; 2006 Mar; 96(2):187-96. PubMed ID: 16319983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen.
    Seeger H; Huober J; Wallwiener D; Mueck AO
    Horm Metab Res; 2004 May; 36(5):277-80. PubMed ID: 15156405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tamoxifen and beta-interferon: effect of simultaneous or sequential treatment on breast cancer cell lines.
    Coradini D; Biffi A; Pirronello E; Di Fronzo G
    Anticancer Res; 1995; 15(2):315-9. PubMed ID: 7763000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific protein synthesis regulated by estrogen in human breast cancer.
    Edwards DP; Adams DJ; McGuire WL
    J Steroid Biochem; 1981 Dec; 15():247-59. PubMed ID: 7339251
    [No Abstract]   [Full Text] [Related]  

  • 26. Estrogen stimulates cell proliferation and the increase of a 52,000 dalton glycoprotein in human breast cancer cells.
    Iacobelli S; Scambia G; Natoli V; Natoli C; Sica G
    J Steroid Biochem; 1984 Mar; 20(3):747-52. PubMed ID: 6708549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 52 K protein: an estrogen regulated marker of cell proliferation in human mammary cells.
    Rochefort H; Capony F; Garcia M; Morisset M; Touïtou I; Vignon F
    Prog Clin Biol Res; 1986; 204():125-40. PubMed ID: 3515355
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro analysis of the cellular proliferative response to 17-beta-estradiol of human breast cancer.
    Podhajcer OL; Bravo AI; Dain L; Guman N; Bover L; Mordoh J
    Cancer; 1988 May; 61(9):1807-12. PubMed ID: 3281743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term tissue culture of human breast cancer: presence of estrogen receptors and 17 beta-estradiol stimulation of RNA synthesis.
    Sanfilippo O; Daidone MG; Di Fronzo G; Silvestrini R
    Cancer; 1979 Jun; 43(6):2365-9. PubMed ID: 455226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of 17 beta estradiol and tamoxifen on the ZR-75-1 human breast cancer cell line in defined medium.
    Allegra JC; Lippman ME
    Eur J Cancer (1965); 1980 Aug; 16(8):1007-15. PubMed ID: 7439217
    [No Abstract]   [Full Text] [Related]  

  • 31. Interaction of prolactin, estrogen and progesterone in a human mammary carcinoma cell line, CAMA-1 - I Cell growth and thymidine uptake.
    Leung BS; Potter AH; Qureshi S
    J Steroid Biochem; 1981 Dec; 15():421-7. PubMed ID: 7339271
    [No Abstract]   [Full Text] [Related]  

  • 32. Estradiol induced proteins in the MCF7 human breast cancer cell line.
    Westley B; Rochefort H
    Biochem Biophys Res Commun; 1979 Sep; 90(2):410-6. PubMed ID: 508310
    [No Abstract]   [Full Text] [Related]  

  • 33. Sex steroid binding protein is a negative modulator of estrogen-induced breast cancer cell growth.
    Frairia R; Fortunati N; Fazzari A; Fissore F; Comba A; Becchis M; Catalano MG; Benedusi-Pagliano E; Berta L; Mauro M; Gaidano G
    Ann N Y Acad Sci; 1996 Apr; 784():362-9. PubMed ID: 8651584
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7).
    Butler WB; Kirkland WL; Jorgensen TL
    Biochem Biophys Res Commun; 1979 Oct; 90(4):1328-34. PubMed ID: 518601
    [No Abstract]   [Full Text] [Related]  

  • 35. Are the proteins in malignant cancer cells of diverse origin similar or different?
    Ling GN; Reid C; Murphy RC
    Physiol Chem Phys Med NMR; 1986; 18(3):147-58. PubMed ID: 3588692
    [No Abstract]   [Full Text] [Related]  

  • 36. Human breast cancer cell growth inhibition and deregulation of [Ca2+]i by estradiol.
    Jain PT; Trump BF
    Anticancer Drugs; 1997 Mar; 8(3):283-7. PubMed ID: 9095334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrinology of the benign breast disease. Current views.
    Pitiş M
    Endocrinologie; 1987; 25(3):135-40. PubMed ID: 3685843
    [No Abstract]   [Full Text] [Related]  

  • 38. Positional isomers of acetaminophen differentially induce proliferation of cultured breast cancer cells.
    Harnagea-Theophilus E; Miller MR; Rao N
    Toxicol Lett; 1999 Jan; 104(1-2):11-8. PubMed ID: 10048744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New cell lines of human breast cancer origin.
    Calaf G; Abarca-Quinones J; Feuilhade F; Beaune J; Dupre G; Orrico M; Barnabas-Sohi N; Kouyoumdjian JC
    Breast Cancer Res Treat; 1992; 21(1):63-75. PubMed ID: 1327292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth stage-related synthesis and secretion of proteins by human neuroblastoma cells and their variants.
    Biedler JL; Rozen MG; el-Badry O; Meyers MB; Melera PW; Ross RA; Spengler BA
    Prog Clin Biol Res; 1985; 175():209-21. PubMed ID: 3873074
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.